Gallagher Duncan 4

What Happened Gallagher Duncan, a director of Health Catalyst, acquired 7,562 restricted stock units (RSUs) on February 17, 2026. The transaction is reported as an award/grant (code A) at $0.00 per unit on the Form 4; a footnote states these RSUs were granted under the 2019 Plan and 100% vested on Feb 17, 2026, converting the RSUs into the right to receive one share per RSU.

Key Details

• Transaction date and type: 2026-02-17 — Grant/Award of 7,562 RSUs (code A) reported at $0.00.
• Shares owned after transaction: Not specified in the provided summary of the filing.
• Footnote: RSUs issued under the Issuer’s 2019 Stock Option and Incentive Plan; each RSU equals one contingent share and 100% vested on Feb 17, 2026 under the Non-Employee Director Compensation Policy.
• Filing timeliness: Form filed Feb 19, 2026 for a Feb 17 transaction — appears timely (not marked late).

Context RSUs are compensation awards that convert into shares when they vest; because these RSUs vested, the insider obtained the underlying share rights. This type of director compensation is routine and does not necessarily signal a buy/sell view by the insider. The filing does not show any tax withholding or immediate sale related to the award.